APA (7th ed.) Citation

Wenfang Sun, Yali Li, Binbin Xia, Jing Chen, Yang Liu, Jingyao Pang, . . . Hua Cheng. (2024). Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: A real-world study based on the FDA adverse event reporting system. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Wenfang Sun, Yali Li, Binbin Xia, Jing Chen, Yang Liu, Jingyao Pang, Fang Liu, and Hua Cheng. Adverse Event Reporting of Four Anti-Calcitonin Gene-related Peptide Monoclonal Antibodies for Migraine Prevention: A Real-world Study Based on the FDA Adverse Event Reporting System. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Wenfang Sun, et al. Adverse Event Reporting of Four Anti-Calcitonin Gene-related Peptide Monoclonal Antibodies for Migraine Prevention: A Real-world Study Based on the FDA Adverse Event Reporting System. Frontiers Media S.A., 2024.